PP
MRNA icon

Prudential plc’s Moderna MRNA Stock Holding History

Prudential plc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,210
Closed -$508K – 797
2024
Q4 		$508K Buy
12,210
+6,722
+122% +$321K ﹤0.01% 618
2024
Q3 		$367K Hold
5,488
– – ﹤0.01% 689
2024
Q2 		$652K Hold
5,488
– – ﹤0.01% 552
2024
Q1 		$585K Sell
5,488
-4,531
-45% -$457K ﹤0.01% 579
2023
Q4 		$996K Buy
10,019
+10
+0.1% +$841 0.01% 571
2023
Q3 		$1.03M Sell
10,009
-1,215
-11% -$136K 0.01% 521
2023
Q2 		$1.36M Sell
11,224
-62
-0.5% -$8.27K 0.02% 487
2023
Q1 		$1.73M Buy
11,286
+23
+0.2% +$3.79K 0.02% 414
2022
Q4 		$2.02M Sell
11,263
-4,022
-26% -$658K 0.03% 375
2022
Q3 		$1.81M Buy
15,285
+5,749
+60% +$872K 0.03% 310
2022
Q2 		$1.36M Buy
9,536
+641
+7% +$91.6K 0.02% 353
2022
Q1 		$1.53M Buy
8,895
+5,706
+179% +$961K 0.02% 355
2021
Q4 		$810K Buy
+3,189
New +$932K 0.01% 406
2021
Q2 		– Sell
-14,515
Closed -$1.9M – 594
2021
Q1 		$1.9M Buy
+14,515
New +$2.1M 0.01% 389

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prudential plc's MRNA Position: Q1 2025 in Review

Prudential plc sold out of Moderna (MRNA) in Q1 2025, closing a stake of 12,210 shares — an estimated $508K sold.

Prudential plc first reported a position in MRNA in Q1 2021 and held it in 14 quarters. The position peaked at $2.02M in Q4 2022. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Prudential plc reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Prudential plc sold 12,210 Moderna shares in Q1 2025, an estimated $508K.
  • Prudential plc first reported a position in Moderna in Q1 2021 and held it in 14 quarters.
  • Prudential plc's Moderna position peaked at $2.02M in Q4 2022.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Prudential plc's 13F filing for Q1 2025, filed 13 May 2025.